Advances in atopic dermatitis

Current Opinion in Immunology

Volumn 23, Issue 6, 2011, Pages 778-783

  Novak, Natalija ^a   Leung, Donald Y M ^b  

^a UNIVERSITY OF BONN   (Germany)

^b DEPARTMENT OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; CD81 ANTIGEN; CD9 ANTIGEN; FOOD ALLERGEN; GAMMA INTERFERON; GAMMA INTERFERON RECEPTOR; IMMUNOGLOBULIN E; INFLAMMASOME; PROTEIN; STAT3 PROTEIN; THYMIC STROMAL LYMPHOPOIETIN; TOLL LIKE RECEPTOR 2;

ADAPTIVE IMMUNITY; ATOPIC DERMATITIS; CELL FUNCTION; DENDRITIC CELL; HISTOPATHOLOGY; HUMAN; IMMUNOMODULATION; INNATE IMMUNITY; LYMPHOCYTIC INFILTRATION; NONHUMAN; PATHOPHYSIOLOGY; PERMEABILITY BARRIER; REVIEW; SKIN DISEASE; T LYMPHOCYTE;

ADAPTIVE IMMUNITY; ANIMALS; DENDRITIC CELLS; DERMATITIS, ATOPIC; HUMANS; IMMUNITY, INNATE; T-LYMPHOCYTES;

EID: 82955233008     PISSN: 09527915     EISSN: 18790372     Source Type: Journal    
DOI: 10.1016/j.coi.2011.09.007     Document Type: Review

References (51)

1. Novak N., Simon D. Atopic dermatitis - from new pathophysiologic insights to individualzed therapy. Allergy 2011, 66:830-839.
2. Brown S.J., Asai Y., Cordell H.J., Campbell L.E., Zhao Y., Liao H., Northstone K., Henderson J., Alizadehfar R., Ben-Shoshan M., et al. Loss-of-function variants in the filaggrin gene are a significant risk factor for peanut allergy. J Allergy Clin Immunol 2011, 127:661-667.
3. Thyssen J.P., Carlsen B.C., Menne T., Linneberg A., Nielsen N.H., Meldgaard M., Szecsi P.B., Stender S., Johansen J.D. Filaggrin null mutations increase the risk and persistence of hand eczema in subjects with atopic dermatitis: results from a general population study. Br J Dermatol 2010, 163:115-120.
4. O'Regan G.M., Irvine A.D. The role of filaggrin in the atopic diathesis. Clin Exp Allergy 2010, 40:965-972.
5. Barnes K.C. An update on the genetics of atopic dermatitis: scratching the surface in 2009. J Allergy Clin Immunol 2010, 125:16-29.
6. Kezic S., O'Regan G.M., Yau N., Sandilands A., Chen H., Campbell L.E., Kroboth K., Watson R., Rowland M., Irwin McLean W.H., et al. Levels of filaggrin degradation products are influenced by both filaggrin genotype and atopic dermatitis severity. Allergy 2011, 66:934-940.
7. O'Regan G.M., Kemperman P.M., Sandilands A., Chen H., Campbell L.E., Kroboth K., Watson R., Rowland M., Puppels G.J., McLean W.H., et al. Raman profiles of the stratum corneum define 3 filaggrin genotype-determined atopic dermatitis endophenotypes. J Allergy Clin Immunol 2010, 126:574-580.
8. Miajlovic H., Fallon P.G., Irvine A.D., Foster T.J. Effect of filaggrin breakdown products on growth of and protein expression by Staphylococcus aureus. J Allergy Clin Immunol 2010, 126:1184-1190.
9. Jakasa I., Koster E.S., Calkoen F., McLean W.H., Campbell L.E., Bos J.D., Verberk M.M., Kezic S. Skin barrier function in healthy subjects and patients with atopic dermatitis in relation to filaggrin loss-of-function mutations. J Invest Dermatol 2011, 131:540-542.
10. Esparza-Gordillo J., Weidinger S., Folster-Holst R., Bauerfeind A., Ruschendorf F., Patone G., Rohde K., Marenholz I., Schulz F., Kerscher T., et al. A common variant on chromosome 11q13 is associated with atopic dermatitis. Nat Genet 2009, 41:596-601.
11. O'Regan G.M., Campbell L.E., Cordell H.J., Irvine A.D., McLean W.H., Brown S.J. Chromosome 11q13.5 variant associated with childhood eczema: an effect supplementary to filaggrin mutations. J Allergy Clin Immunol 2010, 125:170-174.
12. Marenholz I., Bauerfeind A., Esparza-Gordillo J., Kerscher T., Granell R., Nickel R., Lau S., Henderson J., Lee Y.A. The eczema risk variant on chromosome 11q13 (rs7927894) in the population-based ALSPAC cohort: a novel susceptibility factor for asthma and hay fever. Hum Mol Genet 2011, 20:2443-2449.
13. Henry J., Hsu C.Y., Haftek M., Nachat R., de Koning H.D., Gardinal-Galera I., Hitomi K., Balica S., Jean-Decoster C., Schmitt A.M., et al. Hornerin is a component of the epidermal cornified cell envelopes. FASEB J 2011, 25:1567-1576.
14. De Benedetto A., Slifka M.K., Rafaels N.M., Kuo I.H., Georas S.N., Boguniewicz M., Hata T., Schneider L.C., Hanifin J.M., Gallo R.L., et al. Reductions in claudin-1 may enhance susceptibility to herpes simplex virus 1 infections in atopic dermatitis. J Allergy Clin Immunol 2011, 128:242-246.
15. Suárez-Fariñas M., Tintle S.J., Shemer A., Chiricozzi A., Nograles K., Cardinale I., Duan S., Bowcock A.M., Krueger J.G., Guttman-Yassky E. Nonlesional atopic dermatitis skin is characterized by broad terminal differentiation defects and variable immune abnormalities. J Allergy Clin Immunol 2011, 127:954-964.
16. Broccardo C.J., Mahaffey S., Schwarz J., Wruck L., David G., Schlievert P.M., Reisdorph N.A., Leung D.Y. Comparative proteomic profiling of patients with atopic dermatitis based on history of eczema herpeticum infection and Staphylococcus aureus colonization. J Allergy Clin Immunol 2011, 127:186-193.
17. Dai X., Sayama K., Tohyama M., Shirakata Y., Hanakawa Y., Tokumaru S., Yang L., Hirakawa S., Hashimoto K. Mite allergen is a danger signal for the skin via activation of inflammasome in keratinocytes. J Allergy Clin Immunol 2011, 127:806-814.
18. Niebuhr M., Heratizadeh A., Wichmann K., Satzger I., Werfel T. Intrinsic alterations of pro-inflammatory mediators in unstimulated and TLR-2 stimulated keratinocytes from atopic dermatitis patients. Exp Dermatol 2011, 20:468-472.
19. Zimmermann M., Koreck A., Meyer N., Basinski T., Meiler F., Simone B., Woehrl S., Moritz K., Eiwegger T., Schmid-Grendelmeier P., et al. TNF-like weak inducer of apoptosis (TWEAK) and TNF-alpha cooperate in the induction of keratinocyte apoptosis. J Allergy Clin Immunol 2011, 127:200-207.
20. Saito M., Nagasawa M., Takada H., Hara T., Tsuchiya S., Agematsu K., Yamada M., Kawamura N., Ariga T., Tsuge I., et al. Defective IL-10 signaling in hyper-IgE syndrome results in impaired generation of tolerogenic dendritic cells and induced regulatory T cells. J Exp Med 2011, 208:235-249.
21. Reginald K., Westritschnig K., Linhart B., Focke-Tejkl M., Jahn-Schmid B., Eckl-Dorna J., Heratizadeh A., Stocklinger A., Balic N., Spitzauer S., et al. Staphylococcus aureus fibronectin-binding protein specifically binds IgE from patients with atopic dermatitis and requires antigen presentation for cellular immune responses. J Allergy Clin Immunol 2011, 128:82-91.
22. Reginald K., Westritschnig K., Werfel T., Heratizadeh A., Novak N., Focke-Tejkl M., Hirschl A.M., Leung D.Y., Elisyutina O., Fedenko E., et al. Immunoglobulin E antibody reactivity to bacterial antigens in atopic dermatitis patients. Clin Exp Allergy 2011, 41:357-369.
23. Ziegler S.F., Artis D. Sensing the outside world: TSLP regulates barrier immunity. Nat Immunol 2010, 11:289-293.
24. Oyoshi M.K., Larson R.P., Ziegler S.F., Geha R.S. Mechanical injury polarizes skin dendritic cells to elicit a T(H)2 response by inducing cutaneous thymic stromal lymphopoietin expression. J Allergy Clin Immunol 2010, 126:976-984.
25. Wu W.H., Park C.O., Oh S.H., Kim H.J., Kwon Y.S., Bae B.G., Noh J.Y., Lee K.H. Thymic stromal lymphopoietin-activated invariant natural killer T cells trigger an innate allergic immune response in atopic dermatitis. J Allergy Clin Immunol 2010, 126:290-299.
26. Gyimesi E., Nagy G., Remenyik E., Sipka S., Zeher M., Biro T., Szegedi A. Altered peripheral invariant natural killer T cells in atopic dermatitis. J Clin Immunol 2011, [Epub ahead of print].
27. Novak N., Koch S., Allam J.P., Bieber T. Dendritic cells: bridging innate and adaptive immunity in atopic dermatitis. J Allergy Clin Immunol 2010, 125:50-59.
28. Voorhees T., Chang J., Yao Y., Kaplan M.H., Chang C.H., Travers J.B. Dendritic cells produce inflammatory cytokines in response to bacterial products from Staphylococcus aureus-infected atopic dermatitis lesions. Cell Immunol 2011, 267:17-22.
29. Peng W.M., Yu C.F., Kolanus W., Mazzocca A., Bieber T., Kraft S., Novak N. Tetraspanins CD9 and CD81 are molecular partners of trimeric FcvarepsilonRI on human antigen-presenting cells. Allergy 2011, 66:605-611.
30. Gros E, Petzold S, Maintz L, Bieber T, Novak N: Reduced interferon-gamma receptor expression and attenuated interferon-γ response by dendritic cells in atopic dermatitis. J Allergy Clin Immunol 2011, in press.
31. Fujita H., Shemer A., Suarez-Farinas M., Johnson-Huang L.M., Tintle S., Cardinale I., Fuentes-Duculan J., Novitskaya I., Carucci J.A., Krueger J.G., et al. Lesional dendritic cells in patients with chronic atopic dermatitis and psoriasis exhibit parallel ability to activate T-cell subsets. J Allergy Clin Immunol 2011, 128:574-582.
32. Hennino A., Jean-Decoster C., Giordano-Labadie F., Debeer S., Vanbervliet B., Rozieres A., Schmitt A.M., Nicolas J.F. CD8+ T cells are recruited early to allergen exposure sites in atopy patch test reactions in human atopic dermatitis. J Allergy Clin Immunol 2011, 127:1064-1067.
33. Lin Y.T., Wang C.T., Chao P.S., Lee J.H., Wang L.C., Yu H.H., Yang Y.H., Chiang B.L. Skin-homing CD4+ Foxp3+ T cells exert Th2-like function after staphylococcal superantigen stimulation in atopic dermatitis patients. Clin Exp Allergy 2011, 41:516-525.
34. Niebuhr M., Scharonow H., Gathmann M., Mamerow D., Werfel T. Staphylococcal exotoxins are strong inducers of IL-22: A potential role in atopic dermatitis. J Allergy Clin Immunol 2010, 126:1176-1183.
35. Niebuhr M., Gathmann M., Scharonow H., Mamerow D., Mommert S., Balaji H., Werfel T. Staphylococcal alpha-toxin is a strong inducer of interleukin-17 in humans. Infect Immun 2011, 79:1615-1622.
36. Nograles K.E., Suarez-Farinas M., Shemer A., Fuentes-Duculan J., Chiricozzi A., Cardinale I., Zaba L.C., Kikuchi T., Ramon M., Bergman R., et al. Atopic dermatitis keratinocytes exhibit normal T(H)17 cytokine responses. J Allergy Clin Immunol 2010, 125:744-746.
37. Souwer Y., Szegedi K., Kapsenberg M.L., de Jong E.C. IL-17 and IL-22 in atopic allergic disease. Curr Opin Immunol 2010, 22:821-826.
38. Gutowska-Owsiak D., Schaupp A.L., Salimi M., Taylor S., Ogg G.S. IL-22 down-regulates filaggrin expression and affects expression of profilaggrin processing enzymes. Br J Dermatol 2011, 165:492-498.
39. Hvid M., Vestergaard C., Kemp K., Christensen G.B., Deleuran B., Deleuran M. IL-25 in atopic dermatitis: a possible link between inflammation and skin barrier dysfunction?. J Invest Dermatol 2011, 131:150-157.
40. Sonkoly E., Janson P., Majuri M.L., Savinko T., Fyhrquist N., Eidsmo L., Xu N., Meisgen F., Wei T., Bradley M., et al. MiR-155 is overexpressed in patients with atopic dermatitis and modulates T-cell proliferative responses by targeting cytotoxic T lymphocyte-associated antigen 4. J Allergy Clin Immunol 2010, 126:581-589.
41. Oyoshi M.K., Elkhal A., Scott J.E., Wurbel M.A., Hornick J.L., Campbell J.J., Geha R.S. Epicutaneous challenge of orally immunized mice redirects antigen-specific gut-homing T cells to the skin. J Clin Invest 2011, 121:2210-2220.
42. Balaji H., Heratizadeh A., Wichmann K., Niebuhr M., Crameri R., Scheynius A., Werfel T. Malassezia sympodialis thioredoxin-specific T cells are highly cross-reactive to human thioredoxin in atopic dermatitis. J Allergy Clin Immunol 2011, 128:92-99.
43. Hinz T., Zaccaro D., Byron M., Brendes K., Krieg T., Novak N., Bieber T. Atopic dermo-respiratory syndrome is a correlate of eczema herpeticum. Allergy 2011, 66:925-933.
44. Freyschmidt E.J., Mathias C.B., Diaz N., MacArthur D.H., Laouar A., Manjunath N., Hofer M.D., Wurbel M.A., Campbell J.J., Chatila T.A., et al. Skin inflammation arising from cutaneous regulatory T cell deficiency leads to impaired viral immune responses. J Immunol 2010, 185:1295-1302.
45. Schneider L., Weinberg A., Boguniewicz M., Taylor P., Oettgen H., Heughan L., Zaccaro D., Armstrong B., Holliday A., Leung D.Y. Immune response to varicella vaccine in children with atopic dermatitis compared with nonatopic controls. J Allergy Clin Immunol 2010, 126:1306-1307.
46. Leung D.Y., Gao P.S., Grigoryev D.N., Rafaels N.M., Streib J.E., Howell M.D., Taylor P.A., Boguniewicz M., Canniff J., Armstrong B., et al. Human atopic dermatitis complicated by eczema herpeticum is associated with abnormalities in IFN-gamma response. J Allergy Clin Immunol 2011, 127:965-973.
47. Gao P.S., Rafaels N.M., Mu D., Hand T., Murray T., Boguniewicz M., Hata T., Schneider L., Hanifin J.M., Gallo R.L., et al. Genetic variants in thymic stromal lymphopoietin are associated with atopic dermatitis and eczema herpeticum. J Allergy Clin Immunol 2010, 125:1403-1407.
48. Gao P.S., Rafaels N.M., Hand T., Murray T., Boguniewicz M., Hata T., Schneider L., Hanifin J.M., Gallo R.L., Gao L., et al. Filaggrin mutations that confer risk of atopic dermatitis confer greater risk for eczema herpeticum. J Allergy Clin Immunol 2009, 124:507-513.
49. Hata T.R., Kotol P., Boguniewicz M., Taylor P., Paik A., Jackson M., Nguyen M., Kabigting F., Miller J., Gerber M., et al. History of eczema herpeticum is associated with the inability to induce human beta-defensin (HBD)-2, HBD-3 and cathelicidin in the skin of patients with atopic dermatitis. Br J Dermatol 2010, 163:659-661.
50. Boguniewicz M., Leung D.Y. Recent insights into atopic dermatitis and implications for management of infectious complications. J Allergy Clin Immunol 2010, 125:4-13.
51. Guttman-Yassky E., Nograles K.E., Krueger J.G. Contrasting pathogenesis of atopic dermatitis and psoriasis: Part II: immune cell subsets and therapeutic concepts. J Allergy Clin Immunol 2011, 127.